While the current evidence supports the pathogenic role of total CD8+ T cells in MASH progression, the application of single-cell genomics has unveiled functionally distinct subsets within the CD8+ T cell population. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.